Literature DB >> 24514872

Clinical trials: Measuring abuse liability--is the risk worth taking?

Eija A Kalso1, Kaarlo Simojoki2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24514872     DOI： 10.1038/nrneurol.2014.16

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

1.  Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010.

Authors:  Benedikt Fischer; Wayne Jones; Murray Krahn; Jürgen Rehm
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-07-13       Impact factor: 2.890

2.  Therapeutic Interactive Voice Response (TIVR) to reduce analgesic medication use for chronic pain management.

Authors:  Magdalena R Naylor; Shelly Naud; Francis J Keefe; John E Helzer
Journal:  J Pain       Date:  2010-12       Impact factor: 5.820

3.  Expect analgesic failure; pursue analgesic success.

Authors:  Andrew Moore; Sheena Derry; Christopher Eccleston; Eija Kalso
Journal:  BMJ       Date:  2013-05-03

4.  Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study.

Authors:  Mark J Edlund; Bradley C Martin; Andrea Devries; Ming-Yu Fan; Jennifer Brennan Braden; Mark D Sullivan
Journal:  Clin J Pain       Date:  2010-01       Impact factor: 3.442

Review 5.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.

Authors:  N Attal; G Cruccu; R Baron; M Haanpää; P Hansson; T S Jensen; T Nurmikko
Journal:  Eur J Neurol       Date:  2010-04-09       Impact factor: 6.089

Review 6.  Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.

Authors:  Nalini Sehgal; Laxmaiah Manchikanti; Howard S Smith
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

7.  Critical issues on opioids in chronic non-cancer pain: an epidemiological study.

Authors:  Jørgen Eriksen; Per Sjøgren; Eduardo Bruera; Ola Ekholm; Niels K Rasmussen
Journal:  Pain       Date:  2006-07-13       Impact factor: 6.961

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

Review 9.  Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.

Authors:  Alec B O'Connor; Dennis C Turk; Robert H Dworkin; Nathaniel P Katz; Robert Colucci; Jennifer A Haythornthwaite; Michael Klein; Charles O'Brien; Kelly Posner; Bob A Rappaport; Gary Reisfield; Edgar H Adams; Robert L Balster; George E Bigelow; Laurie B Burke; Sandra D Comer; Edward Cone; Penney Cowan; Richard A Denisco; John T Farrar; Richard W Foltin; David J Haddox; Sharon Hertz; Gary W Jay; Roderick Junor; Ernest A Kopecky; Deborah B Leiderman; Michael P McDermott; Pamela P Palmer; Srinivasa N Raja; Christine Rauschkolb; Michael C Rowbotham; Cristina Sampaio; Beatrice Setnik; Shannon M Smith; Marta Sokolowska; Joseph W Stauffer; Sharon L Walsh; James P Zacny
Journal:  Pain       Date:  2013-11       Impact factor: 6.961
  9 in total
  1 in total

1.  Abuse liability-study the intended patient populations.

Authors:  Alec B O'Connor; Dennis C Turk; Robert H Dworkin
Journal:  Nat Rev Neurol       Date:  2015-02-10       Impact factor: 42.937
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.